Cerebrospinal Fluid Management Market By Type (CSF shunts, External drainage system), By Age group (Pediatric, Adult): Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The Cerebral Spinal Fluid Management Market valued for $675.44 million in 2021 and is estimated to reach $1,032.56 million by 2031, exhibiting a CAGR of 4.4% from 2022 to 2031.

Hydrocephalus refers to the buildup of fluid in the ventricles deep within the brain. The excess fluid called cerebral spinal fluid increases the size of the ventricles and puts pressure on the brain. It can be treated with the use of cerebral spinal fluid management devices. Cerebrospinal fluid (CSF) management devices involve the devices such as shunts and external drainage systems to maintain the flow of CSF and drain excess fluid from the brain. Increased intracranial pressure can result in irreversible injury to the central nervous system. It provides protection against acute changes in venous and arterial blood pressure or impact pressure. Nevertheless, trauma, tumors, infections, neurosurgical procedures, and other factors can cause increased intracranial pressure. Both surgical and nonsurgical therapeutic modalities can be used in the management of increased intracranial pressure attributable to traumatic and non-traumatic causes. In patients with cerebral injury and increased intracranial pressure, monitoring of the intracranial pressure can provide an objective measure of the response to therapy and the pressure dynamics. Intraventricular, intraparenchymal, subarachnoid, and epidural sites can be used for monitoring, and the advantages and disadvantages of the various devices available.

The growth of the cerebral spinal fluid management market is driven by increase in the number of brain surgeries, surge in number of research and development activities, rise in expenditure on the product development by the government & private organizations and increase in the technological advancements of the cerebral spinal fluid management devices and increase in the number of research laboratories. Moreover, the disruption of normal cerebral spinal fluid circulation and turnover is believed to contribute to the development of many neurodegenerative conditions such as Alzheimer's disease, ischemic and traumatic brain injury, and neuroinflammatory conditions such as multiple sclerosis. Hence, increase in the adoption of cerebral spinal fluid management devices boosts the growth of the market. In addition, increase in the research pipeline among the pharmaceutical and biotechnology research organizations and surge in awareness about research studies on the conditions of disrupted volume of cerebral spinal fluid foster the growth of the market. For instance, according to the study of National Library of Medicine, in June 2021, there were 687 neurosurgery admissions in India during the study period compared with 2550 admissions in 2019. The total number of surgeries performed in neurosurgery also showed a similar trend, with only 654 surgeries in 2020 compared with 3165 surgeries in 2019. Moreover, increase in the geriatric population which are more prone to the neurological disorders are also contributing in the demand of the market. However, the high cost of the treatment for cerebral spinal fluid related diseases is expected to hinder the growth of the market.

The cerebral spinal fluid management market is segmented on the basis of type, age group and region. On the basis of type, the market is bifurcated into CSF shunts and external drainage system. On the basis of age group, the market is classified into pediatric and adult. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major companies profiled in the report include: B. Braun Melsungen AG, Delta Surgical, G. SURGIWEAR LTD, Integra Lifesciences Holdings, Medtronic plc, Moller Medical GMBH, Natus Medical Incorporated, Spiegelberg GmbH & Co. KG, Tokibo Co., Ltd., and Wellong Pharma.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cerebral spinal fluid management market analysis from 2021 to 2031 to identify the prevailing cerebral spinal fluid management market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cerebral spinal fluid management market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cerebral spinal fluid management market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

CSF shunts
External drainage system

By Age group

Pediatric
Adult

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players

B. Braun Melsungen AG
Delta Surgical
Spiegelberg GmbH & Co. KG
Moller Medical GmbH
Tokibo Co.,Ltd
Medtronic plc
G. Surgiwear Ltd.
Integra LifeSciences Holdings
Wellona Pharma
Natus Medical Incorporated

Product Code: A10924

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in the prevalence of brain disorders
  - 3.4.1.2. Increase in the geriatric population
  - 3.4.1.3. Rise in demand for development in the CSF shunts
- 3.4.2. Restraints
  - 3.4.2.1. Complications related to the shunts
- 3.4.3. Opportunities
  - 3.4.3.1. Rise in the of research and developments (R&D) activities
3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. CSF shunts
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. External drainage system
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY AGE GROUP

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Pediatric
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Adult
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country

CHAPTER 6: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY REGION

6.1. Overview
- 6.1.1. Market size and forecast By Region
6.2. North America
- 6.2.1. Key trends and opportunities
- 6.2.2. Market size and forecast, by Type
- 6.2.3. Market size and forecast, by Age group
- 6.2.4. Market size and forecast, by country
  - 6.2.4.1. U.S.
  - 6.2.4.1.1. Key market trends, growth factors and opportunities
  - 6.2.4.1.2. Market size and forecast, by Type
  - 6.2.4.1.3. Market size and forecast, by Age group
  - 6.2.4.2. Canada
  - 6.2.4.2.1. Key market trends, growth factors and opportunities
  - 6.2.4.2.2. Market size and forecast, by Type
  - 6.2.4.2.3. Market size and forecast, by Age group
  - 6.2.4.3. Mexico
  - 6.2.4.3.1. Key market trends, growth factors and opportunities
  - 6.2.4.3.2. Market size and forecast, by Type
  - 6.2.4.3.3. Market size and forecast, by Age group
6.3. Europe
- 6.3.1. Key trends and opportunities
- 6.3.2. Market size and forecast, by Type
- 6.3.3. Market size and forecast, by Age group
- 6.3.4. Market size and forecast, by country
  - 6.3.4.1. Germany
  - 6.3.4.1.1. Key market trends, growth factors and opportunities
  - 6.3.4.1.2. Market size and forecast, by Type
  - 6.3.4.1.3. Market size and forecast, by Age group
  - 6.3.4.2. France
  - 6.3.4.2.1. Key market trends, growth factors and opportunities
  - 6.3.4.2.2. Market size and forecast, by Type
  - 6.3.4.2.3. Market size and forecast, by Age group
  - 6.3.4.3. UK
  - 6.3.4.3.1. Key market trends, growth factors and opportunities
  - 6.3.4.3.2. Market size and forecast, by Type
  - 6.3.4.3.3. Market size and forecast, by Age group
  - 6.3.4.4. Italy
  - 6.3.4.4.1. Key market trends, growth factors and opportunities
  - 6.3.4.4.2. Market size and forecast, by Type
  - 6.3.4.4.3. Market size and forecast, by Age group
  - 6.3.4.5. Spain
  - 6.3.4.5.1. Key market trends, growth factors and opportunities
  - 6.3.4.5.2. Market size and forecast, by Type
  - 6.3.4.5.3. Market size and forecast, by Age group
  - 6.3.4.6. Rest of Europe
  - 6.3.4.6.1. Key market trends, growth factors and opportunities
  - 6.3.4.6.2. Market size and forecast, by Type
  - 6.3.4.6.3. Market size and forecast, by Age group
6.4. Asia-Pacific
- 6.4.1. Key trends and opportunities
- 6.4.2. Market size and forecast, by Type
- 6.4.3. Market size and forecast, by Age group
- 6.4.4. Market size and forecast, by country
  - 6.4.4.1. China
  - 6.4.4.1.1. Key market trends, growth factors and opportunities
  - 6.4.4.1.2. Market size and forecast, by Type
  - 6.4.4.1.3. Market size and forecast, by Age group
  - 6.4.4.2. Japan
  - 6.4.4.2.1. Key market trends, growth factors and opportunities
  - 6.4.4.2.2. Market size and forecast, by Type
  - 6.4.4.2.3. Market size and forecast, by Age group
  - 6.4.4.3. India
  - 6.4.4.3.1. Key market trends, growth factors and opportunities
  - 6.4.4.3.2. Market size and forecast, by Type
  - 6.4.4.3.3. Market size and forecast, by Age group
  - 6.4.4.4. Australia
  - 6.4.4.4.1. Key market trends, growth factors and opportunities
  - 6.4.4.4.2. Market size and forecast, by Type
  - 6.4.4.4.3. Market size and forecast, by Age group
  - 6.4.4.5. South Korea
  - 6.4.4.5.1. Key market trends, growth factors and opportunities
  - 6.4.4.5.2. Market size and forecast, by Type
  - 6.4.4.5.3. Market size and forecast, by Age group
  - 6.4.4.6. Rest of Asia-Pacific
  - 6.4.4.6.1. Key market trends, growth factors and opportunities
  - 6.4.4.6.2. Market size and forecast, by Type
  - 6.4.4.6.3. Market size and forecast, by Age group
6.5. LAMEA
- 6.5.1. Key trends and opportunities
- 6.5.2. Market size and forecast, by Type
- 6.5.3. Market size and forecast, by Age group
- 6.5.4. Market size and forecast, by country
  - 6.5.4.1. Brazil
  - 6.5.4.1.1. Key market trends, growth factors and opportunities
  - 6.5.4.1.2. Market size and forecast, by Type
  - 6.5.4.1.3. Market size and forecast, by Age group
  - 6.5.4.2. Saudi Arabia
  - 6.5.4.2.1. Key market trends, growth factors and opportunities
  - 6.5.4.2.2. Market size and forecast, by Type
  - 6.5.4.2.3. Market size and forecast, by Age group
  - 6.5.4.3. South Africa
  - 6.5.4.3.1. Key market trends, growth factors and opportunities
  - 6.5.4.3.2. Market size and forecast, by Type
  - 6.5.4.3.3. Market size and forecast, by Age group
  - 6.5.4.4. Rest of LAMEA
  - 6.5.4.4.1. Key market trends, growth factors and opportunities
  - 6.5.4.4.2. Market size and forecast, by Type
  - 6.5.4.4.3. Market size and forecast, by Age group

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

8.1. Medtronic plc
- 8.1.1. Company overview
- 8.1.2. Key Executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
8.2. B. Braun Melsungen AG
- 8.2.1. Company overview
- 8.2.2. Key Executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
8.3. Integra LifeSciences Holdings
- 8.3.1. Company overview
- 8.3.2. Key Executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
8.4. Wellona Pharma
- 8.4.1. Company overview
- 8.4.2. Key Executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
8.5. Delta Surgical
- 8.5.1. Company overview
- 8.5.2. Key Executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
8.6. Spiegelberg GmbH & Co. KG
- 8.6.1. Company overview
- 8.6.2. Key Executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
8.7. G. Surgiwear Ltd.
- 8.7.1. Company overview
- 8.7.2. Key Executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
8.8. Moller Medical GmbH
- 8.8.1. Company overview
- 8.8.2. Key Executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
8.9. Natus Medical Incorporated
- 8.9.1. Company overview
- 8.9.2. Key Executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
8.10. Tokibo Co.,Ltd
- 8.10.1. Company overview
- 8.10.2. Key Executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio